The Innovation Firm

When

November 29, 2016
12:00 - 1:30 p.m.

Where

MassBio
300 Technology Square, 8th Floor
Cambridge, MA 02139

EVENT RECORDING: Strategies and Considerations for Protecting Your Medical Technology Start-Up’s Innovations

Hamilton Brook Smith Reynolds with
Guest Speakers Dr. Jeff Chabot, Co-Founder/Member of the Board of Directors at Endocellutions, Inc. and
David Feinberg, Managing Partner at Feinberg Hanson LLP

 

Protecting Your Start-Up’s Medical Technology InnovationsIn partnership with the Massachusetts Biotechnology Council (MassBio), we invite you to come for lunch and learn how medical technology companies are reaping rewards by protecting their core technologies/products through strategic procurement and use of intellectual property (IP) rights. 

The business environment for startup companies is hazardous, particularly for those based on technical innovation.  Small medical device companies are especially susceptible because of the multidisciplinary technical nature of the field and because the field is so competitive.  While the success of medical technology companies is often contingent on intellectual property protection, that is only the start.  The strategic leveraging of company assets, including intellectual property, also requires a thorough knowledge of the general legal environment and larger strategic options available to the company as it grows.

This is an interactive panel discussion with Hamilton Brook Smith Reynolds intellectual property attorneys Scott Pierce and Alexander Adam and guest speakers Dr. Jeff Chabot, Co-Founder and Member of the Board of Directors of Endocellutions, Inc., and David Feinberg of Feinberg Hanson LLP.  Endocellutions, Inc. is a start-up medical device company developing innovative solutions to enable regenerative medicine.  Feinberg Hanson LLP is a Boston law firm specializing in mergers and acquisitions, venture capital and private equity, and licensing and strategic partnerships. 

The panel will discuss the importance of

  • Identifying and protecting your company’s intellectual property assets
  • Tactical management of intellectual property
  • The role of intellectual property in the strategic management of your company, including mergers and acquisitions, obtaining venture capital and private equity investments, and licensing and strategic partnerships
  • Critical legal focus points for entrepreneurs in building and protecting their businesses

Guest Speakers

 

Jeff Chabot, Ph.D.
Co-Founder/Member of the Board of Directors, Endocellutions, Inc.

Dr. Chabot holds advanced degrees in physics (MIT) and engineering (Northeastern University), is a co-founder and member of the Board of Directors of Endocellutions, and is the lead inventor of several of Endocellutions’ core technologies. He has significant experience exploring the interface between physical and biological sciences and to the application of physical and engineering approaches to biomedical needs.  He has a strong working knowledge of growth factors, cellular protein synthesis and related pathways, and stem cells, as well as mechanical and electrical engineering.  Dr. Chabot is currently an Associate Research Fellow employed by Pfizer, Inc., a leading pharmaceutical company.

 

David Feinberg

David Feinberg
Managing Partner, Feinberg Hanson LLP

David formed Feinberg Hanson LLP to focus his professional energy on representing entrepreneurs and investors in venture-backed and pre-venture businesses. With over 20 years of corporate law experience, Mr. Feinberg’s core expertise is in corporate and venture finance, mergers and acquisitions and the general corporate representation of technology and other companies. He has been listed in Chambers USA as a leading corporate and M&A attorney and has also been named a Massachusetts Super Lawyer. A graduate of Harvard College and Harvard Law School, Mr. Feinberg spent five years as a corporate associate at Cravath, Swaine & Moore in New York City. In 1992, Mr. Feinberg joined Foley Hoag LLP, where he served as a partner until he resigned from his partnership to form an internet start-up in 2000. After selling his company, he formed the predecessor to Feinberg Hanson LLP to help energize start-ups and entrepreneurial businesses.

 

Panelists

Scott Pierce

Scott Pierce
Hamilton Brook Smith Reynolds

Scott has been practicing intellectual property law for over 25 years.  In addition to preparing and prosecuting U.S. and foreign patent applications, he files and prosecutes trademark applications, conducts due diligence analyses and prepares legal opinions directed to patent infringement, inventorship and validity issues.  He reviews license agreements, supports litigation, and sits on client patent committees.  Scott practices in the areas of biotechnology, chemistry, chemical engineering, electronics, medical devices, and pharmaceuticals.  He is also an adjunct professor at Suffolk University Law School and the author of several published academic articles on the subject of patent law.  More...
 

Alex Adam

Alexander Adam
Hamilton Brook Smith Reynolds

Alex specializes in drafting and prosecuting patent applications in the fields of computer systems, electronics, imaging software, control systems, mechanical devices, medical devices, telecommunications, and clean energy.  He also has experience in patent litigation, due diligence, and providing invalidity and non-infringement opinions.  Alex advises clients on U.S. and international patent strategy.  More...

 

Overview

When

November 29, 2016
12:00 - 1:30 p.m.

Where

MassBio
300 Technology Square, 8th Floor
Cambridge, MA 02139

Hamilton Brook Smith Reynolds with
Guest Speakers Dr. Jeff Chabot, Co-Founder/Member of the Board of Directors at Endocellutions, Inc. and
David Feinberg, Managing Partner at Feinberg Hanson LLP

 

Protecting Your Start-Up’s Medical Technology InnovationsIn partnership with the Massachusetts Biotechnology Council (MassBio), we invite you to come for lunch and learn how medical technology companies are reaping rewards by protecting their core technologies/products through strategic procurement and use of intellectual property (IP) rights. 

The business environment for startup companies is hazardous, particularly for those based on technical innovation.  Small medical device companies are especially susceptible because of the multidisciplinary technical nature of the field and because the field is so competitive.  While the success of medical technology companies is often contingent on intellectual property protection, that is only the start.  The strategic leveraging of company assets, including intellectual property, also requires a thorough knowledge of the general legal environment and larger strategic options available to the company as it grows.

This is an interactive panel discussion with Hamilton Brook Smith Reynolds intellectual property attorneys Scott Pierce and Alexander Adam and guest speakers Dr. Jeff Chabot, Co-Founder and Member of the Board of Directors of Endocellutions, Inc., and David Feinberg of Feinberg Hanson LLP.  Endocellutions, Inc. is a start-up medical device company developing innovative solutions to enable regenerative medicine.  Feinberg Hanson LLP is a Boston law firm specializing in mergers and acquisitions, venture capital and private equity, and licensing and strategic partnerships. 

The panel will discuss the importance of

  • Identifying and protecting your company’s intellectual property assets
  • Tactical management of intellectual property
  • The role of intellectual property in the strategic management of your company, including mergers and acquisitions, obtaining venture capital and private equity investments, and licensing and strategic partnerships
  • Critical legal focus points for entrepreneurs in building and protecting their businesses
Presenter Bios

Guest Speakers

 

Jeff Chabot, Ph.D.
Co-Founder/Member of the Board of Directors, Endocellutions, Inc.

Dr. Chabot holds advanced degrees in physics (MIT) and engineering (Northeastern University), is a co-founder and member of the Board of Directors of Endocellutions, and is the lead inventor of several of Endocellutions’ core technologies. He has significant experience exploring the interface between physical and biological sciences and to the application of physical and engineering approaches to biomedical needs.  He has a strong working knowledge of growth factors, cellular protein synthesis and related pathways, and stem cells, as well as mechanical and electrical engineering.  Dr. Chabot is currently an Associate Research Fellow employed by Pfizer, Inc., a leading pharmaceutical company.

 

David Feinberg

David Feinberg
Managing Partner, Feinberg Hanson LLP

David formed Feinberg Hanson LLP to focus his professional energy on representing entrepreneurs and investors in venture-backed and pre-venture businesses. With over 20 years of corporate law experience, Mr. Feinberg’s core expertise is in corporate and venture finance, mergers and acquisitions and the general corporate representation of technology and other companies. He has been listed in Chambers USA as a leading corporate and M&A attorney and has also been named a Massachusetts Super Lawyer. A graduate of Harvard College and Harvard Law School, Mr. Feinberg spent five years as a corporate associate at Cravath, Swaine & Moore in New York City. In 1992, Mr. Feinberg joined Foley Hoag LLP, where he served as a partner until he resigned from his partnership to form an internet start-up in 2000. After selling his company, he formed the predecessor to Feinberg Hanson LLP to help energize start-ups and entrepreneurial businesses.

 

Panelists

Scott Pierce

Scott Pierce
Hamilton Brook Smith Reynolds

Scott has been practicing intellectual property law for over 25 years.  In addition to preparing and prosecuting U.S. and foreign patent applications, he files and prosecutes trademark applications, conducts due diligence analyses and prepares legal opinions directed to patent infringement, inventorship and validity issues.  He reviews license agreements, supports litigation, and sits on client patent committees.  Scott practices in the areas of biotechnology, chemistry, chemical engineering, electronics, medical devices, and pharmaceuticals.  He is also an adjunct professor at Suffolk University Law School and the author of several published academic articles on the subject of patent law.  More...
 

Alex Adam

Alexander Adam
Hamilton Brook Smith Reynolds

Alex specializes in drafting and prosecuting patent applications in the fields of computer systems, electronics, imaging software, control systems, mechanical devices, medical devices, telecommunications, and clean energy.  He also has experience in patent litigation, due diligence, and providing invalidity and non-infringement opinions.  Alex advises clients on U.S. and international patent strategy.  More...

 

Back to the Top